Sample result

GLP-1, a diabetes hormone

A saved result, shown read-only. Sign in to run your own searches. A new account gets a free 30-day trial.

The search

Query: GLP-1 · 31 lettersHAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG
From: UniProt P01275, residues 98 to 128
Search: Protein → Patent proteins · Automatic (Smith-Waterman)
Set: Public patent sequences: Patent proteins, snapshot 2026-11-05-c456f6bdba29
Ran: 2026-11-12
Found: 5,000 sequences, 3,061 publications, 1,851 families

Smith-Waterman compares each query with every stored sequence. Each query returns up to 5,000 sequences, with the best alignment of each. FASTA36 fits its E-values to a random sample of scores, so a sequence near the cutoff can come and go between runs. These results do not establish patentability.

Patents

3,061 publications in 1,851 families match these filters.

US 8685895-B22014-04-01

Methods for selecting protease resistant polypeptides

Query Match 97.5%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | |||||||||||||||||||||||||||||
Hit    1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
30 of 31 identical, no gaps.
US 8729018-B22014-05-20

Therapeutic agents comprising elastic peptides

Duke University

Query Match 97.5%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | |||||||||||||||||||||||||||||
Hit    1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
30 of 31 identical, no gaps.
US 8734796-B22014-05-27

Carrier immunoglobulins

Amgen Inc.

Query Match 97.5%Identity 96.8%Family of 4
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | |||||||||||||||||||||||||||||
Hit    1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
30 of 31 identical, no gaps.
Family of 4
Grouped by the same title and applicant. No priority claim is on record.
- US 8734796-B22014-05-27
- US 9562107-B22017-02-07
- US 9562108-B22017-02-07
- US 10189912-B22019-01-29
US 8841255-B22014-09-23

Therapeutic agents comprising fusions of vasoactive intestinal peptide and elastic peptides

Duke University

Query Match 97.5%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | |||||||||||||||||||||||||||||
Hit    1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
30 of 31 identical, no gaps.
EP 2894168-A12015-07-15

GLUCAGON-LIKE PEPTIDE-1 ANALOGUE MONOMER AND DIMER, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

TIANJIN INST PHARM RESEARCH

Query Match 97.5%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         ||||||||||||||||||||||| |||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFICWLVKGRG 31
```
30 of 31 identical, no gaps.
US 9127047-B22015-09-08

Therapeutic agents comprising insulin and elastin-like peptides

DUKE UNIVERSITY

Query Match 97.5%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | |||||||||||||||||||||||||||||
Hit    1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
30 of 31 identical, no gaps.
US 9200083-B22015-12-01

Methods of treating diabetes using therapeutic agents comprising a GLP-1 receptor agonist and elastin-like peptides

DUKE UNIVERSITY

Query Match 97.5%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | |||||||||||||||||||||||||||||
Hit    1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
30 of 31 identical, no gaps.
JP 2015231380-A2015-12-24

Methods for selecting protease resistant polypeptides

Glaxo Group Limited,Carolyn Enever,Laurent Jespers,Malgorzata Pupecka, Ian Tomlinson

Query Match 97.5%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | |||||||||||||||||||||||||||||
Hit    1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
30 of 31 identical, no gaps.
JP 2016505627-A2016-02-25

THERAPEUTIC AGENTS, COMPOSITIONS, AND METHODS FOR GLYCEMIC CONTROL

Phasebio Pharmaceuticals Inc

Query Match 97.5%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | |||||||||||||||||||||||||||||
Hit    1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
30 of 31 identical, no gaps.
US 9328154-B22016-05-03

Therapeutic agents comprising fusions of growth hormone and elastic peptides

DUKE UNIVERSITY

Query Match 97.5%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | |||||||||||||||||||||||||||||
Hit    1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
30 of 31 identical, no gaps.
US 9458218-B22016-10-04

Therapeutic agents comprising fusions of insulin and elastic peptides

DUKE UNIVERSITY

Query Match 97.5%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | |||||||||||||||||||||||||||||
Hit    1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
30 of 31 identical, no gaps.
US 9821036-B22017-11-21

Therapeutic agents comprising a GLP-2 peptide and elastin-like peptides

DUKE UNIVERSITY

Query Match 97.5%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | |||||||||||||||||||||||||||||
Hit    1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
30 of 31 identical, no gaps.
JP 2018500291-A2018-01-11

ELP FUSION PROTEINS FOR CONTROLLED AND SUSTAINED RELEASE

PhaseBio Pharmaceuticals Inc

Query Match 97.5%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | |||||||||||||||||||||||||||||
Hit    1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
30 of 31 identical, no gaps.
Family of 2
Grouped by a shared priority claim, US 62/082945.
- JP 2018500291-A2018-01-11
- JP 2022176986-A2022-11-30
EP 3272877-A12018-01-24

B-CELL-MIMETIC CELLS

ETH ZUERICH

Query Match 97.5%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | |||||||||||||||||||||||||||||
Hit    1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
30 of 31 identical, no gaps.
WO 2018015330-A12018-01-25

B-CELL-MIMETIC CELLS

ETH ZUERICH

Query Match 97.5%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | |||||||||||||||||||||||||||||
Hit    1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
30 of 31 identical, no gaps.
US 9919032-B22018-03-20

Method for administering a sustained release formulation

PHASEBIO PHARMACEUTICALS, INC.

Query Match 97.5%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | |||||||||||||||||||||||||||||
Hit    1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
30 of 31 identical, no gaps.
WO 2018107064-A12018-06-14

TISSUE ORGANOIDS

UNIV CHICAGO

Query Match 97.5%Identity 96.8%
Best alignment
Query 1 to 31, hit 21 to 51. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | |||||||||||||||||||||||||||||
Hit   21 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 51
```
30 of 31 identical, no gaps.
US 10302655-B22019-05-28

Methods for selecting protease resistant polypeptides

Query Match 97.5%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | |||||||||||||||||||||||||||||
Hit    1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
30 of 31 identical, no gaps.
JP 2019520837-A2019-07-25

B-CELL-MIMETIC CELLS

ETH Zurich

Query Match 97.5%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | |||||||||||||||||||||||||||||
Hit    1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
30 of 31 identical, no gaps.
US 10466252-B22019-11-05

Methods for selecting protease resistant polypeptides

Query Match 97.5%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | |||||||||||||||||||||||||||||
Hit    1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
30 of 31 identical, no gaps.
US 10596230-B22020-03-24

Methods of increasing nutrient absorption in the intestine using therapeutic agents comprising GLP-2 and elastin-like peptides

DUKE UNIVERSITY

Query Match 97.5%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | |||||||||||||||||||||||||||||
Hit    1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
30 of 31 identical, no gaps.
WO 2020148317-A12020-07-23

PEPTIDE-OLIGOUREA HYBRID COMPOUNDS

UREKA SARL

Query Match 97.5%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | |||||||||||||||||||||||||||||
Hit    1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
30 of 31 identical, no gaps.
KR 1020210089102-A2021-07-15

FUSION PROTEIN COMPRISING ALBUMIN AND COILED COIL FORMING DOMAIN, AND BISPECFIC TARGET CONJUGATE USING THE SAME

HK inno.N Corporation

Query Match 97.5%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | |||||||||||||||||||||||||||||
Hit    1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
30 of 31 identical, no gaps.
US 11103558-B22021-08-31

Therapeutic agents comprising a BMP-9 peptide and eleastin-like peptides

Duke University

Query Match 97.5%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | |||||||||||||||||||||||||||||
Hit    1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
30 of 31 identical, no gaps.
US 11285219-B22022-03-29

Peptide-oligourea hybrid compounds

UREKA SARL and Centre National de la Recherche Scientifique (CNRS)

Query Match 97.5%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | |||||||||||||||||||||||||||||
Hit    1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
30 of 31 identical, no gaps.
KR 1020230147711-A2023-10-23

METHODS FOR LIGATION OF (POLY)PEPTIDES AND OLIGONUCLEOTIDES

NANYANG TECHNOLOGICAL UNIVERSITY

Query Match 97.5%Identity 96.8%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | |||||||||||||||||||||||||||||
Hit    1 HXEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
30 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020230147711-A2023-10-23
- JP 2024508800-A2024-02-28
EP 4272830-A22023-11-08

TISSUE ORGANOIDS

UNIV CHICAGO

Query Match 97.5%Identity 96.8%
Best alignment
Query 1 to 31, hit 21 to 51. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | |||||||||||||||||||||||||||||
Hit   21 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 51
```
30 of 31 identical, no gaps.
WO 2025240560-A22025-11-20

GLP-1 FORMULATIONS AND THEIR USES

ROSE PHARMA INC

Query Match 97.5%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | |||||||||||||||||||||||||||||
Hit    1 HVEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
30 of 31 identical, no gaps.
EP 4803098-A12026-09-09

GIPR BLOCKING TYPE ANTIBODY AND ANTIBODY CONJUGATE THEREOF

SHANDONG BOAN BIOTECHNOLOGY CO LTD

Query Match 97.5%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         | |||||||||||||||||||||||||||||
Hit    1 HXEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
30 of 31 identical, no gaps.
US 8071103-B22011-12-06

Pharmaceutical composition comprising a human GLP-1 mimetibody

Centocor, Inc.

Query Match 96.9%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         ||||||||||||||||||||||| |||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIEWLVKGRG 31
```
30 of 31 identical, no gaps.
WO 2021214220-A12021-10-28

GLUCAGON ANALOGUES AS LONG-ACTING GLP-1/GLUCAGON RECEPTOR AGONISTS IN THE TREATMENT OF FATTY LIVER DISEASE AND STEATOHEPATITIS

BOEHRINGER INGELHEIM INT

Query Match 96.9%Identity 93.5%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         |||||||||||||||||||||| |||| |||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFLAWLVRGRG 31
```
29 of 31 identical, no gaps.
KR 1020230005289-A2023-01-09

GLUCAGON ANALOGUES AS LONG-ACTING GLP-1/GLUCAGON RECEPTOR AGONISTS IN THE TREATMENT OF FATTY LIVER DISEASE AND STEATOHEPATITIS

BOEHRINGER INGELHEIM INTERNATIONAL GMBH

Query Match 96.9%Identity 93.5%Family of 4
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         |||||||||||||||||||||| |||| |||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFLAWLVRGRG 31
```
29 of 31 identical, no gaps.
Family of 4
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020230005289-A2023-01-09
- JP 2023522364-A2023-05-30
- US 11813312-B22023-11-14
- US 12378296-B22025-08-05
WO 2025069009-A12025-04-03

ROCK2 INHIBITORS IN THE TREATMENT OF OBESITY

GRAVITON BIOSCIENCE BV

Query Match 96.9%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         |||||||||||||||| ||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGNAAKEFIAWLVKGRG 31
```
30 of 31 identical, no gaps.
US 5424286-A1995-06-13

Exendin-3 and exendin-4 polypeptides, and pharmaceutical compositions comprising same

Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
US 5631224-A1997-05-20

Use of a peptide

Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
US 5912229-A1999-06-15

Use of a pharmaceutical composition comprising an appetite-suppressing peptide

Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 7 to 36. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    7 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 36
```
30 of 30 identical, no gaps.
WO 9946283-A11999-09-16

Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis

LARSEN BJARNE DUE (DK)

Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
US 5977071-A1999-11-02

Glucagon-like insulinotropic peptides, compositions and methods

Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
US 5985627-A1999-11-16

Modified carboxypeptidase

Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
KR 1020007008023-A2000-07-21

PROCESS FOR MAKING DESIRED POLYPEPTIDES IN YEAST

Query Match 96.3%Identity 93.5%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         ||||||||||||||||||| ||||||| |||
Hit    1 HAEGTFTSDVSSYLEGQAAREFIAWLVRGRG 31
```
29 of 31 identical, no gaps.
US 6133235-A2000-10-17

Glucagon-like insulinotropic peptides compositions and methods

Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
WO 0066629-A12000-11-09

Modified exendins and exendin agonists

AMYLIN PHARMACEUTICALS, INC. (US)

Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
US 6187579-A2001-02-13

Customized proteases

Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 7 to 36. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    7 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 36
```
30 of 30 identical, no gaps.
WO 0117568-A22001-03-15

Pulmonary delivery for bioconjugation

Conjuchem, Inc. (CA)

Query Match 96.3%Identity 100.0%Family of 3
Best alignment and family
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
Family of 3
Grouped by the same title and applicant. No priority claim is on record.
- WO 0117568-A22001-03-15
- JP 2003508501-A2003-03-04
- US 6706892-A2004-03-16
WO 0123420-A22001-04-05

Pituitary adenylate cyclase activating peptide (pacap) receptor 3 (r3) agonists and their pharmacological methods of use

Bayer Corporation (US)

Query Match 96.3%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- WO 0123420-A22001-04-05
- US 7507714-A2009-03-24
KR 1020017008904-A2001-07-13

NOVEL EXENDIN AGONIST FORMULATIONS AND METHODS OF ADMINISTRATIONTHEREOF

Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
JP 2001513638-A2001-09-04

Modified carboxypeptidase

CARLSBERG LABORATORY

Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
JP 2001278807-A2001-10-10

Enterokinesis inhibitor

ITOHAM FOODS INC

Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 7 to 36. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    7 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 36
```
30 of 30 identical, no gaps.
JP 2002509078-A2002-03-26

Inotropic and diuretic effects of exendin and GLP-1

AMYLIN PHARMACEUTICALS INC

Query Match 96.3%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- JP 2002509078-A2002-03-26
- US 6703359-A2004-03-09
JP 2002509082-A2002-03-26

Pharmacologically active peptide complex with reduced tendency against enzymatic hydrolysis

ZEALAND PHARMACEUTICALS AS

Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.

GLP-1, a diabetes hormone

The search

Patents

Family of 4

Family of 2

Family of 2

Family of 4

Family of 3

Family of 2

Family of 2